TreeWAS – Variant ID: rs3800308

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.1 Disorders of iron metabolism	0.000	0.000	1.000
C44 Other malignant neoplasms of skin	0.971	0.029	0.000
C44.4 Skin of scalp and neck	0.970	0.030	0.000
C44.3 Skin of other and unspecified parts of face	0.955	0.045	0.000
C44.1 Skin of eyelid, including canthus	0.946	0.054	0.000
C44.2 Skin of ear and external auricular canal	0.931	0.069	0.000
L40.9 Psoriasis, unspecified	0.907	0.093	0.000
C44.7 Skin of lower limb, including hip	0.878	0.122	0.000
C44.5 Skin of trunk	0.712	0.288	0.000
C44.8 Overlapping lesion of skin	0.696	0.304	0.000
E83 Disorders of mineral metabolism	0.000	0.343	0.657
C44.0 Skin of lip	0.652	0.348	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.619	0.380	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.401	0.599
E83.3 Disorders of phosphorus metabolism	0.000	0.417	0.583
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.529	0.471
E83.8 Other disorders of mineral metabolism	0.000	0.529	0.471
E83.2 Disorders of zinc metabolism	0.000	0.529	0.471
E83.0 Disorders of copper metabolism	0.000	0.529	0.471
C44.6 Skin of upper limb, including shoulder	0.399	0.601	0.000
L40 Psoriasis	0.382	0.618	0.000
L40.8 Other psoriasis	0.307	0.693	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.303	0.696	0.000
L40.0 Psoriasis vulgaris	0.303	0.697	0.000
L40.4 Guttate psoriasis	0.274	0.726	0.000
L40.3 Pustulosis palmaris et plantaris	0.274	0.726	0.000
L40.2 Acrodermatitis continua	0.274	0.726	0.000
L40.1 Generalised pustular psoriasis	0.274	0.726	0.000
C43 Malignant melanoma of skin	0.167	0.833	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.154	0.846	0.000
I12.0 Hypertensive renal disease with renal failure	0.153	0.847	0.000
C43.5 Malignant melanoma of trunk	0.137	0.863	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.120	0.880	0.000
C43.8 Overlapping malignant melanoma of skin	0.120	0.880	0.000
C43.0 Malignant melanoma of lip	0.120	0.880	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.117	0.883	0.000
L40.5 Arthropathic psoriasis	0.113	0.886	0.000
C43.9 Malignant melanoma of skin, unspecified	0.103	0.897	0.000
C43.4 Malignant melanoma of scalp and neck	0.091	0.909	0.000
E83.5 Disorders of calcium metabolism	0.000	0.911	0.088
L40-L45 Papulosquamous disorders	0.082	0.918	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.081	0.919	0.000
K90.0 Coeliac disease	0.000	0.926	0.074
I12 Hypertensive renal disease	0.070	0.930	0.000
L44 Other papulosquamous disorders	0.059	0.941	0.000
L41 Parapsoriasis	0.059	0.941	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.059	0.941	0.000
I12.9 Hypertensive renal disease without renal failure	0.051	0.949	0.000
L42 Pityriasis rosea	0.050	0.950	0.000
K90 Intestinal malabsorption	0.000	0.953	0.046
K90.9 Intestinal malabsorption, unspecified	0.000	0.957	0.043
L41.9 Parapsoriasis, unspecified	0.042	0.958	0.000
L41.8 Other parapsoriasis	0.042	0.958	0.000
L41.5 Retiform parapsoriasis	0.042	0.958	0.000
L41.4 Large plaque parapsoriasis	0.042	0.958	0.000
L41.3 Small plaque parapsoriasis	0.042	0.958	0.000
L41.2 Lymphomatoid papulosis	0.042	0.958	0.000
L41.1 Pityriasis lichenoides chronica	0.042	0.958	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.042	0.958	0.000
L44.9 Papulosquamous disorder, unspecified	0.042	0.958	0.000
L44.8 Other specified papulosquamous disorders	0.042	0.958	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.042	0.958	0.000
L44.3 Lichen ruber moniliformis	0.042	0.958	0.000
L44.2 Lichen striatus	0.042	0.958	0.000
L44.1 Lichen nitidus	0.042	0.958	0.000
L44.0 Pityriasis rubra pilaris	0.042	0.958	0.000
L43 Lichen planus	0.036	0.963	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.036	0.964	0.000
K90.8 Other intestinal malabsorption	0.000	0.966	0.033
K90.3 Pancreatic steatorrhoea	0.000	0.966	0.033
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.966	0.033
K90.1 Tropical sprue	0.000	0.966	0.033
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.972	0.028
L43.3 Subacute (active) lichen planus	0.026	0.973	0.000
L43.2 Lichenoid drug reaction	0.026	0.973	0.000
L43.1 Bullous lichen planus	0.026	0.973	0.000
L43.0 Hypertrophic lichen planus	0.026	0.973	0.000
L43.8 Other lichen planus	0.024	0.976	0.000
M75.1 Rotator cuff syndrome	0.016	0.984	0.000
C78.0 Secondary malignant neoplasm of lung	0.014	0.986	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.013	0.987	0.000
L43.9 Lichen planus, unspecified	0.010	0.990	0.000
C78.7 Secondary malignant neoplasm of liver	0.010	0.990	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.009	0.991	0.000
D68.2 Hereditary deficiency of other clotting factors	0.000	0.992	0.008
C78.4 Secondary malignant neoplasm of small intestine	0.008	0.992	0.000
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.000	0.992	0.008
I10-I15 Hypertensive diseases	0.008	0.992	0.000
E70-E90 Metabolic disorders	0.000	0.992	0.008
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.008	0.992	0.000
C78.2 Secondary malignant neoplasm of pleura	0.008	0.992	0.000
E85 Amyloidosis	0.000	0.993	0.007
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.007	0.993	0.000
H35.8 Other specified retinal disorders	0.000	0.993	0.007
K91.3 Postoperative intestinal obstruction	0.007	0.993	0.000
E85.4 Organ-limited amyloidosis	0.000	0.993	0.007
H35.6 Retinal haemorrhage	0.000	0.993	0.007
E85.9 Amyloidosis, unspecified	0.000	0.994	0.006
E73 Lactose intolerance	0.000	0.994	0.006
I13 Hypertensive heart and renal disease	0.006	0.994	0.000
E79 Disorders of purine and pyrimidine metabolism	0.000	0.994	0.006
E77 Disorders of glycoprotein metabolism	0.000	0.994	0.006
E76 Disorders of glycosaminoglycan metabolism	0.000	0.994	0.006
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.000	0.994	0.006
E72 Other disorders of amino-acid metabolism	0.000	0.994	0.006
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.000	0.994	0.006
E70 Disorders of aromatic amino-acid metabolism	0.000	0.994	0.006
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.000	0.994	0.006
G82.2 Paraplegia, unspecified	0.006	0.994	0.000
I15 Secondary hypertension	0.006	0.994	0.000
E85.8 Other amyloidosis	0.000	0.994	0.005
E85.3 Secondary systemic amyloidosis	0.000	0.994	0.005
E85.2 Heredofamilial amyloidosis, unspecified	0.000	0.994	0.005
E85.1 Neuropathic heredofamilial amyloidosis	0.000	0.994	0.005
E85.0 Nonneuropathic heredofamilial amyloidosis	0.000	0.994	0.005
C78.1 Secondary malignant neoplasm of mediastinum	0.005	0.994	0.000
E84 Cystic fibrosis	0.000	0.994	0.005
K91.9 Postprocedural disorder of digestive system, unspecified	0.005	0.994	0.000
E74 Other disorders of carbohydrate metabolism	0.000	0.995	0.005
K91.5 Postcholecystectomy syndrome	0.005	0.995	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.005	0.995	0.000
H35 Other retinal disorders	0.000	0.995	0.005
K91.1 Postgastric surgery syndromes	0.005	0.995	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.005	0.995	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.005	0.995	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.005	0.995	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.005	0.995	0.000
H35.7 Separation of retinal layers	0.000	0.995	0.005
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.995	0.005
I11 Hypertensive heart disease	0.005	0.995	0.000
H35.0 Background retinopathy and retinal vascular changes	0.000	0.995	0.005
E80 Disorders of porphyrin and bilirubin metabolism	0.000	0.995	0.005
E73.9 Lactose intolerance, unspecified	0.000	0.995	0.005
E73.8 Other lactose intolerance	0.000	0.995	0.004
E73.1 Secondary lactase deficiency	0.000	0.995	0.004
E73.0 Congenital lactase deficiency	0.000	0.995	0.004
C82.3 Follicular lymphoma grade IIIa	0.004	0.995	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.004	0.995	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.004	0.995	0.000
I13.1 Hypertensive heart and renal disease with renal failure	0.004	0.995	0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.004	0.995	0.000
I15.9 Seconday hypertension, unspecified	0.004	0.995	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.005	0.995	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.000	0.995	0.004
E70.8 Other disorders of aromatic amino-acid metabolism	0.000	0.995	0.004
E70.3 Albinism	0.000	0.995	0.004
E70.2 Disorders of tyrosine metabolism	0.000	0.995	0.004
E70.1 Other hyperphenylalaninaemias	0.000	0.995	0.004
E70.0 Classical phenylketonuria	0.000	0.995	0.004
E71.3 Disorders of fatty-acid metabolism	0.000	0.995	0.004
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.000	0.995	0.004
E71.1 Other disorders of branched-chain amino-acid metabolism	0.000	0.995	0.004
E71.0 Maple-syrup-urine disease	0.000	0.995	0.004
E72.9 Disorder of amino-acid metabolism, unspecified	0.000	0.995	0.004
E72.8 Other specified disorders of amino-acid metabolism	0.000	0.995	0.004
E72.5 Disorders of glycine metabolism	0.000	0.995	0.004
E72.4 Disorders of ornithine metabolism	0.000	0.995	0.004
E72.3 Disorders of lysine and hydroxylysine metabolism	0.000	0.995	0.004
E72.2 Disorders of urea cycle metabolism	0.000	0.995	0.004
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.000	0.995	0.004
E72.0 Disorders of amino-acid transport	0.000	0.995	0.004
E75.6 Lipid storage disorder, unspecified	0.000	0.995	0.004
E75.5 Other lipid storage disorders	0.000	0.995	0.004
E75.4 Neuronal ceroid lipofuscinosis	0.000	0.995	0.004
E75.3 Sphingolipidosis, unspecified	0.000	0.995	0.004
E75.2 Other sphingolipidosis	0.000	0.995	0.004
E75.1 Other gangliosidosis	0.000	0.995	0.004
E75.0 GM2 gangliosidosis	0.000	0.995	0.004
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.000	0.995	0.004
E76.8 Other disorders of glucosaminoglycan metabolism	0.000	0.995	0.004
E76.3 Mucopolysaccharidosis, unspecified	0.000	0.995	0.004
E76.2 Other mucopolysaccharidoses	0.000	0.995	0.004
E76.1 Mucopolysaccharidosis, type II	0.000	0.995	0.004
E76.0 Mucopolysaccharidosis, type I	0.000	0.995	0.004
E77.9 Disorder of glycoprotein metabolism, unspecified	0.000	0.995	0.004
E77.8 Other disorders of glycoprotein metabolism	0.000	0.995	0.004
E77.1 Defects in glycoprotein degradation	0.000	0.995	0.004
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.000	0.995	0.004
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.000	0.995	0.004
E79.8 Other disorders of purine and pyrimidine metabolism	0.000	0.995	0.004
E79.1 Lesch-Nyhan syndrome	0.000	0.995	0.004
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.000	0.995	0.004
C19 Malignant neoplasm of rectosigmoid junction	0.005	0.995	0.000
K04.5 Chronic apical periodontitis	0.004	0.996	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.004	0.996	0.000
H35.9 Retinal disorder, unspecified	0.000	0.996	0.004
K91.4 Colostomy and enterostomy malfunction	0.004	0.996	0.000
I15.8 Other secondary hypertension	0.004	0.996	0.000
I15.2 Hypertension secondary to endocrine disorders	0.004	0.996	0.000
I15.0 Renovascular hypertension	0.004	0.996	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
F52.2 Failure of genital response	0.004	0.996	0.000
C82.0 Small cleaved cell, follicular	0.004	0.996	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.004	0.996	0.000
E84.8 Cystic fibrosis with other manifestations	0.000	0.996	0.004
E84.1 Cystic fibrosis with intestinal manifestations	0.000	0.996	0.004
E84.0 Cystic fibrosis with pulmonary manifestations	0.000	0.996	0.004
E74.9 Disorder of carbohydrate metabolism, unspecified	0.000	0.996	0.004
E74.8 Other specified disorders of carbohydrate metabolism	0.000	0.996	0.004
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.000	0.996	0.004
E74.2 Disorders of galactose metabolism	0.000	0.996	0.004
E74.1 Disorders of fructose metabolism	0.000	0.996	0.004
E74.0 Glycogen storage disease	0.000	0.996	0.004
C84.4 Peripheral T-cell lymphoma	0.004	0.996	0.000
G82 Paraplegia and tetraplegia	0.004	0.996	0.000
H35.1 Retinopathy of prematurity	0.000	0.996	0.004
E89.3 Postprocedural hypopituitarism	0.000	0.996	0.004
T91.3 Sequelae of injury of spinal cord	0.004	0.996	0.000
C95 Leukaemia of unspecified cell type	0.004	0.996	0.000
M47.8 Other spondylosis	0.004	0.996	0.000
I15.1 Hypertension secondary to other renal disorders	0.004	0.996	0.000
E88 Other metabolic disorders	0.000	0.996	0.004
C82.6 Cutaneous follicle centre lymphoma	0.004	0.996	0.000
C82.5 Diffuse follicle centre lymphoma	0.004	0.996	0.000
C82.4 Follicular lymphoma grade IIIb	0.004	0.996	0.000
K90-K93 Other diseases of the digestive system	0.001	0.996	0.003
C84.0 Mycosis fungoides	0.004	0.996	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.004	0.996	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.004	0.996	0.000
E84.9 Cystic fibrosis, unspecified	0.000	0.996	0.004
C86 Other specified types of T/NK-cell lymphoma	0.004	0.996	0.000
T91.2 Sequelae of other fracture of thorax and pelvis	0.004	0.996	0.000
C82.2 Large cell, follicular	0.004	0.996	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.004	0.996	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.000	0.996	0.004
C84.5 Other and unspecified T-cell lymphomas	0.004	0.996	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.000	0.996	0.004
E89.8 Other postprocedural endocrine and metabolic disorders	0.000	0.996	0.004
E89.5 Postprocedural testicular hypofunction	0.000	0.996	0.004
E89.4 Postprocedural ovarian failure	0.000	0.996	0.004
E89.1 Postprocedural hypoinsulinaemia	0.000	0.996	0.004
H35.4 Peripheral retinal degeneration	0.000	0.996	0.004
M47.89 Other spondylosis (Site unspecified)	0.004	0.996	0.000
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.004	0.996	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.004	0.996	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.004	0.996	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.000	0.996	0.003
E80.6 Other disorders of bilirubin metabolism	0.000	0.996	0.003
E80.5 Crigler-Najjar syndrome	0.000	0.996	0.003
E80.3 Defects of catalase and peroxydase	0.000	0.996	0.003
E80.2 Other porphyria	0.000	0.996	0.003
E80.1 Porphyria cutanea tarda	0.000	0.996	0.003
E80.0 Hereditary erythropoietic porphyria	0.000	0.996	0.003
I51.9 Heart disease, unspecified	0.000	0.996	0.004
T91 Sequelae of injuries of neck and trunk	0.004	0.996	0.000
C95.0 Acute leukaemia of unspecified cell type	0.004	0.996	0.000
G82.1 Spastic paraplegia	0.004	0.996	0.000
H35.2 Other proliferative retinopathy	0.000	0.996	0.003
T93.9 Sequelae of unspecified injury of lower limb	0.000	0.996	0.004
M47.83 Other spondylosis (Cervicothoracic region)	0.004	0.996	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.003	0.996	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.004	0.996	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.003	0.996	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.003	0.996	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.003	0.996	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.003	0.996	0.000
C84.3 Lymphoepithelioid lymphoma	0.003	0.996	0.000
C84.2 T-zone lymphoma	0.003	0.996	0.000
C84.1 Sezary's diease	0.003	0.996	0.000
E89.2 Postprocedural hypoparathyroidism	0.000	0.996	0.003
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.003	0.996	0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.003	0.996	0.000
T91.1 Sequelae of fracture of spine	0.003	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
G82.5 Tetraplegia, unspecified	0.003	0.997	0.000
M47.82 Other spondylosis (Cervical region)	0.003	0.997	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.000	0.997	0.003
N48.4 Impotence of organic origin	0.003	0.997	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C94 Other leukaemias of specified cell type	0.003	0.997	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.003	0.997	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.997	0.003
C93 Monocytic leukaemia	0.003	0.997	0.000
M45 Ankylosing spondylitis	0.003	0.997	0.000
C83.0 Small cell (diffuse)	0.003	0.997	0.000
C18.6 Descending colon	0.003	0.997	0.000
C88 Malignant immunoproliferative diseases	0.003	0.997	0.000
T93 Sequelae of injuries of lower limb	0.000	0.997	0.003
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.000	0.997	0.003
H35.5 Hereditary retinal dystrophy	0.000	0.997	0.003
Z73.9 Problem related to life-management difficulty, unspecified	0.000	0.997	0.003
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.000
G82.3 Flaccid tetraplegia	0.003	0.997	0.000
G82.0 Flaccid paraplegia	0.003	0.997	0.000
C92 Myeloid leukaemia	0.003	0.997	0.000
C83.1 Small cleaved cell (diffuse)	0.003	0.997	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.000	0.997	0.003
C95.7 Other leukaemia of unspecified cell type	0.003	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.003	0.997	0.000
Z93.3 Colostomy status	0.003	0.997	0.000
M47.85 Other spondylosis (Thoracolumbar region)	0.003	0.997	0.000
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.003	0.997	0.000
E88.9 Metabolic disorder, unspecified	0.000	0.997	0.003
E88.3 Tumour lysis syndrome	0.000	0.997	0.003
E88.1 Lipodystrophy, not elsewhere classified	0.000	0.997	0.003
D68 Other coagulation defects	0.000	0.997	0.003
D68.8 Other specified coagulation defects	0.000	0.997	0.003
T91.8 Sequelae of other specified injuries of neck and trunk	0.003	0.997	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.001	0.997	0.003
C83.6 Undifferentiated (diffuse)	0.003	0.997	0.000
C83.5 Lymphoblastic (diffuse)	0.003	0.997	0.000
C83.4 Immunoblastic (diffuse)	0.003	0.997	0.000
C83.2 Mixed small and large cell (diffuse)	0.003	0.997	0.000
I08.0 Disorders of both mitral and aortic valves	0.000	0.997	0.003
C83.7 Burkitt's tumour	0.003	0.997	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.003	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.003	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.003	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.003	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.003	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.003	0.997	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.003	0.997	0.000
M47.84 Other spondylosis (Thoracic region)	0.003	0.997	0.000
I08 Multiple valve diseases	0.000	0.997	0.003
M47 Spondylosis	0.003	0.997	0.000
C81 Hodgkin's disease	0.003	0.997	0.000
G82.4 Spastic tetraplegia	0.003	0.997	0.000
O82.0 Delivery by elective Caesarean section	0.000	0.997	0.003
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.003	0.997	0.000
T91.4 Sequelae of injury of intrathoracic organs	0.003	0.997	0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.003	0.997	0.000
H26.4 After-cataract	0.003	0.997	0.000
W19.4 Street and highway	0.003	0.997	0.000
C91 Lymphoid leukaemia	0.003	0.997	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.003	0.997	0.000
M45.X2 Ankylosing spondylitis (Cervical region)	0.003	0.997	0.000
C95.9 Leukaemia, unspecified	0.003	0.997	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.003	0.997	0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.000	0.997	0.003
C83.3 Large cell (diffuse)	0.003	0.997	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.997	0.003
T93.0 Sequelae of open wound of lower limb	0.000	0.997	0.003
I08.8 Other multiple valve diseases	0.000	0.997	0.003
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.997	0.003
I08.2 Disorders of both aortic and tricuspid valves	0.000	0.997	0.003
Chapter II Neoplasms	0.003	0.997	0.000
C94.7 Other specified leukaemias	0.002	0.997	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.997	0.000
C94.5 Acute myelofibrosis	0.002	0.997	0.000
C94.4 Acute panmyelosis	0.002	0.997	0.000
C94.3 Mast cell leukaemia	0.002	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.997	0.000
C94.1 Chronic erythraemia	0.002	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.997	0.000
C96.8 Histiocytic sarcoma	0.002	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.997	0.000
C96.3 True histiocytic lymphoma	0.002	0.997	0.000
C96.2 Malignant mast cell tumour	0.002	0.997	0.000
C96.1 Malignant histiocytosis	0.002	0.997	0.000
C96.0 Letterer-Siwe disease	0.002	0.997	0.000
C71 Malignant neoplasm of brain	0.003	0.997	0.000
M47.1 Other spondylosis with myelopathy	0.003	0.997	0.000
T91.9 Sequelae of unspecified injury of neck and trunk	0.003	0.997	0.000
T93.1 Sequelae of fracture of femur	0.000	0.997	0.003
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.003	0.997	0.000
C93.9 Monocytic leukaemia, unspecified	0.002	0.997	0.000
C93.7 Other monocytic leukaemia	0.002	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.997	0.000
C93.0 Acute monocytic leukaemia	0.002	0.997	0.000
E89.0 Postprocedural hypothyroidism	0.000	0.997	0.003
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.003	0.997	0.000
M45.X6 Ankylosing spondylitis (Lumbar region)	0.003	0.997	0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.003	0.997	0.000
M45.X4 Ankylosing spondylitis (Thoracic region)	0.003	0.997	0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.003	0.997	0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.003	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.002	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.002	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.002	0.997	0.000
C88.2 Gamma heavy chain disease	0.002	0.997	0.000
C88.1 Alpha heavy chain disease	0.002	0.997	0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.000	0.997	0.003
T93.4 Sequelae of injury of nerve of lower limb	0.000	0.997	0.003
C93.1 Chronic monocytic leukaemia	0.002	0.997	0.000
D68.5 Primary Thrombophilia	0.000	0.997	0.003
E88.8 Other specified metabolic disorders	0.000	0.997	0.002
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.997	0.003
T93.2 Sequelae of other fractures of lower limb	0.000	0.997	0.003
C92.9 Myeloid leukaemia, unspecified	0.002	0.997	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.997	0.000
C92.7 Other myeloid leukaemia	0.002	0.997	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.997	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.997	0.000
C92.3 Myeloid sarcoma	0.002	0.997	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.997	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.003	0.997	0.000
E88.2 Lipomatosis, not elsewhere classified	0.000	0.997	0.002
F52 Sexual dysfunction, not caused by organic disorder or disease	0.002	0.997	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.002	0.997	0.000
Z73.3 Stress, not elsewhere classified	0.000	0.997	0.003
Z87.2 Personal history of diseases of the skin and subcutaneous tissue	0.003	0.997	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.001	0.997	0.002
K93.1 Megacolon in Chagas' disease	0.001	0.997	0.002
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.001	0.997	0.002
C76 Malignant neoplasm of other and ill-defined sites	0.002	0.997	0.000
M47.12 Other spondylosis with myelopathy (Cervical region)	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
E86 Volume depletion	0.000	0.998	0.002
C15-C26 Malignant neoplasms of digestive organs	0.002	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.998	0.002
D68.0 Von Willebrand's disease	0.000	0.998	0.002
M47.0 Anterior spinal and vertebral artery compression syndromes	0.002	0.998	0.000
C81.7 Other Hodgkin's disease	0.002	0.998	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.002	0.998	0.000
C81.3 Lymphocytic depletion	0.002	0.998	0.000
C81.2 Mixed cellularity	0.002	0.998	0.000
C81.0 Lymphocytic predominance	0.002	0.998	0.000
C17.0 Duodenum	0.002	0.998	0.000
C90.2 Plasmacytoma, extramedullary	0.002	0.998	0.000
E80.4 Gilbert's syndrome	0.000	0.998	0.002
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.002	0.998	0.000
C18.8 Overlapping lesion of colon	0.002	0.998	0.000
C18 Malignant neoplasm of colon	0.002	0.998	0.000
M45-M49 Spondylopathies	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.002	0.998	0.000
C71.3 Parietal lobe	0.002	0.998	0.000
C71.2 Temporal lobe	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
C71.4 Occipital lobe	0.002	0.998	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.002	0.998	0.000
C91.7 Other lymphoid leukaemia	0.002	0.998	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.002	0.998	0.000
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
C91.3 Prolymphocytic leukaemia	0.002	0.998	0.000
C91.2 Subacute lymphocytic leukaemia	0.002	0.998	0.000
I49.8 Other specified cardiac arrhythmias	0.002	0.998	0.000
C17 Malignant neoplasm of small intestine	0.002	0.998	0.000
Z73 Problems related to life-management difficulty	0.000	0.998	0.002
G80-G83 Cerebral palsy and other paralytic syndromes	0.002	0.998	0.000
M47.2 Other spondylosis with radiculopathy	0.002	0.998	0.000
Z36.8 Other antenatal screening	0.000	0.998	0.002
C71.9 Brain, unspecified	0.002	0.998	0.000
C90.3 Solitary plasmacytoma	0.002	0.998	0.000
C90.1 Plasma cell leukaemia	0.002	0.998	0.000
C18.7 Sigmoid colon	0.002	0.998	0.000
D68.4 Acquired coagulation factor deficiency	0.000	0.998	0.002
E29.1 Testicular hypofunction	0.002	0.998	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
C71.7 Brain stem	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
C71.5 Cerebral ventricle	0.002	0.998	0.000
D68.1 Hereditary factor XI deficiency	0.000	0.998	0.002
N13.3 Other and unspecified hydronephrosis	0.002	0.998	0.000
R49.0 Dysphonia	0.002	0.998	0.000
M47.19 Other spondylosis with myelopathy (Site unspecified)	0.002	0.998	0.000
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M47.17 Other spondylosis with myelopathy (Lumbosacral region)	0.002	0.998	0.000
M47.16 Other spondylosis with myelopathy (Lumbar region)	0.002	0.998	0.000
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)	0.002	0.998	0.000
M47.14 Other spondylosis with myelopathy (Thoracic region)	0.002	0.998	0.000
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)	0.002	0.998	0.000
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)	0.002	0.998	0.000
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)	0.002	0.998	0.000
C91.0 Acute lymphoblastic leukaemia	0.002	0.998	0.000
D68.6 Other Thrombophilia	0.000	0.998	0.002
J86.9 Pyothorax without fistula	0.002	0.998	0.000
S67.0 Crushing injury of thumb and other finger(s)	0.002	0.998	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.002	0.998	0.000
C70 Malignant neoplasm of meninges	0.002	0.998	0.000
G83 Other paralytic syndromes	0.002	0.998	0.000
H55 Nystagmus and other irregular eye movements	0.002	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.002	0.998	0.000
C76.3 Pelvis	0.002	0.998	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.7 Excessive sexual drive	0.002	0.998	0.000
F52.6 Nonorganic dyspareunia	0.002	0.998	0.000
F52.5 Nonorganic vaginismus	0.002	0.998	0.000
F52.4 Premature ejaculation	0.002	0.998	0.000
F52.3 Orgasmic dysfunction	0.002	0.998	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.002	0.998	0.000
F52.0 Lack or loss of sexual desire	0.002	0.998	0.000
G83.4 Cauda equina syndrome	0.002	0.998	0.000
Z73.8 Other problems related to life-management difficulty	0.000	0.998	0.002
G80 Infantile cerebral palsy	0.002	0.998	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.002	0.998	0.000
M23.30 Other meniscus derangements (Multiple sites)	0.000	0.998	0.002
M47.99 Spondylosis, unspecified (Site unspecified)	0.002	0.998	0.000
C18.1 Appendix	0.002	0.998	0.000
C17.1 Jejunum	0.002	0.998	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.002	0.998	0.000
C76.7 Other ill-defined sites	0.002	0.998	0.000
C76.5 Lower limb	0.002	0.998	0.000
C76.4 Upper limb	0.002	0.998	0.000
C76.2 Abdomen	0.002	0.998	0.000
C76.1 Thorax	0.002	0.998	0.000
C18.5 Splenic flexure	0.002	0.998	0.000
C76.0 Head, face and neck	0.002	0.998	0.000
E21.0 Primary hyperparathyroidism	0.002	0.998	0.000
I08.9 Multiple valve disease, unspecified	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations